Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.

Cytomegalovirus viremia associated with increased mortality in cryptococcal meningitis in sub-Saharan Africa.

Skipper CP, Schleiss MR, Bangdiwala AS, Hernandez-Alvarado N, Taseera K, Nabeta HW, Musubire AK, Lofgren SM, Wiesner DL, Rhein J, Rajasingham R, Schutz C, Meintjes G, Muzoora C, Meya DB, Boulware DR; COAT Team.

Clin Infect Dis. 2019 Sep 1. pii: ciz864. doi: 10.1093/cid/ciz864. [Epub ahead of print]

PMID:
31504335
2.

Short course amphotericin B in addition to sertraline and fluconazole for treatment of HIV-associated cryptococcal meningitis in rural Tanzania.

Katende A, Mbwanji G, Faini D, Nyuri A, Kalinjuma AV, Mnzava D, Hullsiek KH, Rhein J, Weisser M, Meya DB, Boulware DR, Letang E; KIULARCO Study Group.

Mycoses. 2019 Aug 28. doi: 10.1111/myc.12995. [Epub ahead of print]

PMID:
31461550
3.

Minimum Inhibitory Concentration Distribution of Fluconazole against Cryptococcus Species and the Fluconazole Exposure Prediction Model.

Chesdachai S, Rajasingham R, Nicol MR, Meya DB, Bongomin F, Abassi M, Skipper C, Kwizera R, Rhein J, Boulware DR.

Open Forum Infect Dis. 2019 Aug 17. pii: ofz369. doi: 10.1093/ofid/ofz369. [Epub ahead of print]

PMID:
31420668
4.

Adjunctive sertraline for HIV-associated cryptococcal meningitis: a randomised, placebo-controlled, double-blind phase 3 trial.

Rhein J, Huppler Hullsiek K, Tugume L, Nuwagira E, Mpoza E, Evans EE, Kiggundu R, Pastick KA, Ssebambulidde K, Akampurira A, Williams DA, Bangdiwala AS, Abassi M, Musubire AK, Nicol MR, Muzoora C, Meya DB, Boulware DR; ASTRO-CM team.

Lancet Infect Dis. 2019 Aug;19(8):843-851. doi: 10.1016/S1473-3099(19)30127-6.

PMID:
31345462
5.

Identification of Pathogen Genomic Differences That Impact Human Immune Response and Disease during Cryptococcus neoformans Infection.

Gerstein AC, Jackson KM, McDonald TR, Wang Y, Lueck BD, Bohjanen S, Smith KD, Akampurira A, Meya DB, Xue C, Boulware DR, Nielsen K.

MBio. 2019 Jul 16;10(4). pii: e01440-19. doi: 10.1128/mBio.01440-19.

6.

Management of amphotericin-induced phlebitis among HIV patients with cryptococcal meningitis in a resource-limited setting: a prospective cohort study.

Ahimbisibwe C, Kwizera R, Ndyetukira JF, Kugonza F, Sadiq A, Hullsiek KH, Williams DA, Rhein J, Boulware DR, Meya DB.

BMC Infect Dis. 2019 Jun 26;19(1):558. doi: 10.1186/s12879-019-4209-7.

7.

Cerebrospinal Fluid and Brain Tissue Penetration of Tenofovir, Lamivudine, and Efavirenz in Postmortem Tissues with Cryptococcal Meningitis.

Nicol MR, Pastick KA, Taylor J, Namuju OC, Rhein J, Williams DA, Meya DB, Boulware DR, Lukande R.

Clin Transl Sci. 2019 Sep;12(5):445-449. doi: 10.1111/cts.12661. Epub 2019 Jul 10.

8.

Essential in vitro diagnostics for advanced HIV and serious fungal diseases: international experts' consensus recommendations.

Bongomin F, Govender NP, Chakrabarti A, Robert-Gangneux F, Boulware DR, Zafar A, Oladele RO, Richardson MD, Gangneux JP, Alastruey-Izquierdo A, Bazira J, Boyles TH, Sarcarlal J, Nacher M, Obayashi T, Worodria W, Pasqualotto AC, Meya DB, Cheng B, Sriruttan C, Muzoora C, Kambugu A, Rodriguez Tudela JL, Jordan A, Chiller TM, Denning DW.

Eur J Clin Microbiol Infect Dis. 2019 Sep;38(9):1581-1584. doi: 10.1007/s10096-019-03600-4. No abstract available.

PMID:
31175479
9.

HIV-Associated Cryptococcal Immune Reconstitution Inflammatory Syndrome Is Associated with Aberrant T Cell Function and Increased Cytokine Responses.

Meya DB, Okurut S, Zziwa G, Cose S, Boulware DR, Janoff EN.

J Fungi (Basel). 2019 May 23;5(2). pii: E42. doi: 10.3390/jof5020042.

10.

Change in plasma CrAg titer is not associated with survival among HIV-infected persons receiving preemptive therapy for asymptomatic cryptococcal antigenemia.

Pullen MF, Kakooza F, Nalintya E, Kiragga AN, Morawski BM, Rajasingham R, Mubiru A, Manabe YC, Kaplan JE, Meya DB, Boulware DR; ORCAS study team.

Clin Infect Dis. 2019 May 22. pii: ciz418. doi: 10.1093/cid/ciz418. [Epub ahead of print] No abstract available.

PMID:
31119280
11.

Burden of fungal asthma in Africa: A systematic review and meta-analysis.

Kwizera R, Musaazi J, Meya DB, Worodria W, Bwanga F, Kajumbula H, Fowler SJ, Kirenga BJ, Gore R, Denning DW.

PLoS One. 2019 May 16;14(5):e0216568. doi: 10.1371/journal.pone.0216568. eCollection 2019.

12.

AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: economic evaluation protocol for a randomised controlled trial-based equivalence study.

Ponatshego PL, Lawrence DS, Youssouf N, Molloy SF, Alufandika M, Bango F, Boulware DR, Chawinga C, Dziwani E, Gondwe E, Hlupeni A, Hosseinipour MC, Kanyama C, Meya DB, Mosepele M, Muthoga C, Muzoora CK, Mwandumba H, Ndhlovu CE, Rajasingham R, Sayed S, Shamu S, Tsholo K, Tugume L, Williams D, Maheswaran H, Shiri T, Boyer-Chammard T, Loyse A, Chen T, Wang D, Lortholary O, Lalloo DG, Meintjes G, Jaffar S, Harrison TS, Jarvis JN, Niessen LW.

BMJ Open. 2019 Apr 1;9(4):e026288. doi: 10.1136/bmjopen-2018-026288.

13.

The Mouse Inhalation Model of Cryptococcus neoformans Infection Recapitulates Strain Virulence in Humans and Shows that Closely Related Strains Can Possess Differential Virulence.

Mukaremera L, McDonald TR, Nielsen JN, Molenaar CJ, Akampurira A, Schutz C, Taseera K, Muzoora C, Meintjes G, Meya DB, Boulware DR, Nielsen K.

Infect Immun. 2019 Apr 23;87(5). pii: e00046-19. doi: 10.1128/IAI.00046-19. Print 2019 Mar.

PMID:
30833336
14.

Epidemiology of non-traumatic spinal cord injury in Uganda: a single center, prospective study with MRI evaluation.

Musubire AK, Meya DB, Katabira ET, Meyer ACL, Bohjanen PR, Boulware DR, Minja F.

BMC Neurol. 2019 Jan 15;19(1):10. doi: 10.1186/s12883-019-1236-3.

15.

Correction to: AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial.

Lawrence DS, Youssouf N, Molloy SF, Alanio A, Alufandika M, Boulware DR, Boyer-Chammard T, Chen T, Dromer F, Hlupeni A, Hope W, Hosseinipour MC, Kanyama C, Lortholary O, Loyse A, Meya DB, Mosepele M, Muzoora C, Mwandumba HC, Ndhlovu CE, Niessen L, Schutz C, Stott KE, Wang D, Lalloo DG, Meintjes G, Jaffar S, Harrison TS, Jarvis JN.

Trials. 2019 Jan 14;20(1):48. doi: 10.1186/s13063-018-3155-9.

16.

Evaluation of a national cryptococcal antigen screening program for HIV-infected patients in Uganda: A cost-effectiveness modeling analysis.

Rajasingham R, Meya DB, Greene GS, Jordan A, Nakawuka M, Chiller TM, Boulware DR, Larson BA.

PLoS One. 2019 Jan 10;14(1):e0210105. doi: 10.1371/journal.pone.0210105. eCollection 2019.

17.

Blood neutrophil counts in HIV-infected patients with cryptococcal meningitis: Association with mortality.

Musubire AK, Meya DB, Rhein J, Meintjes G, Bohjanen PR, Nuwagira E, Muzoora C, Boulware DR, Hullsiek KH; COAT and ASTRO trial teams.

PLoS One. 2018 Dec 31;13(12):e0209337. doi: 10.1371/journal.pone.0209337. eCollection 2018.

18.

Detection of Cryptococcus DNA by Metagenomic Next-generation Sequencing in Symptomatic Cryptococcal Antigenemia.

Ramachandran PS, Cresswell FV, Meya DB, Langelier C, Crawford ED, DeRisi JL, Boulware DR, Wilson MR.

Clin Infect Dis. 2019 May 17;68(11):1978-1979. doi: 10.1093/cid/ciy1024. No abstract available.

PMID:
30535266
19.

AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial.

Lawrence DS, Youssouf N, Molloy SF, Alanio A, Alufandika M, Boulware DR, Boyer-Chammard T, Chen T, Dromer F, Hlupeni A, Hope W, Hosseinipour MC, Kanyama C, Lortholary O, Loyse A, Meya DB, Mosepele M, Muzoora C, Mwandumba HC, Ndhlovu CE, Niessen L, Schutz C, Stott KE, Wang D, Lalloo DG, Meintjes G, Jaffar S, Harrison TS, Jarvis JN.

Trials. 2018 Nov 23;19(1):649. doi: 10.1186/s13063-018-3026-4. Erratum in: Trials. 2019 Jan 14;20(1):48.

20.

Reflexive Laboratory-Based Cryptococcal Antigen Screening and Preemptive Fluconazole Therapy for Cryptococcal Antigenemia in HIV-Infected Individuals With CD4 <100 Cells/µL: A Stepped-Wedge, Cluster-Randomized Trial.

Meya DB, Kiragga AN, Nalintya E, Morawski BM, Rajasingham R, Park BJ, Mubiru A, Kaplan JE, Manabe YC, Boulware DR.

J Acquir Immune Defic Syndr. 2019 Feb 1;80(2):182-189. doi: 10.1097/QAI.0000000000001894.

21.

HIV-Associated Cryptococcal Meningitis Occurring at Relatively Higher CD4 Counts.

Tugume L, Rhein J, Hullsiek KH, Mpoza E, Kiggundu R, Ssebambulidde K, Schutz C, Taseera K, Williams DA, Abassi M, Muzoora C, Musubire AK, Meintjes G, Meya DB, Boulware DR; COAT and ASTRO-CM teams .

J Infect Dis. 2019 Feb 23;219(6):877-883. doi: 10.1093/infdis/jiy602.

PMID:
30325463
22.

Symptomatic Cryptococcal Antigenemia Presenting as Early Cryptococcal Meningitis With Negative Cerebral Spinal Fluid Analysis.

Ssebambulidde K, Bangdiwala AS, Kwizera R, Kandole TK, Tugume L, Kiggundu R, Mpoza E, Nuwagira E, Williams DA, Lofgren SM, Abassi M, Musubire AK, Cresswell FV, Rhein J, Muzoora C, Hullsiek KH, Boulware DR, Meya DB; Adjunctive Sertraline for Treatment of HIV-associated Cryptococcal Meningitis Team .

Clin Infect Dis. 2019 May 30;68(12):2094-2098. doi: 10.1093/cid/ciy817.

PMID:
30256903
23.

Detrimental Outcomes of Unmasking Cryptococcal Meningitis With Recent ART Initiation.

Rhein J, Hullsiek KH, Evans EE, Tugume L, Nuwagira E, Ssebambulidde K, Kiggundu R, Mpoza E, Musubire AK, Bangdiwala AS, Bahr NC, Williams DA, Abassi M, Muzoora C, Meya DB, Boulware DR; ASTRO-CM study team .

Open Forum Infect Dis. 2018 May 24;5(8):ofy122. doi: 10.1093/ofid/ofy122. eCollection 2018 Aug.

24.

A qualitative evaluation of an implementation study for cryptococcal antigen screening and treatment in Uganda.

Lofgren SM, Nalintya E, Meya DB, Boulware DR, Rajasingham R.

Medicine (Baltimore). 2018 Aug;97(31):e11722. doi: 10.1097/MD.0000000000011722.

25.

Detection of Mycobacterium tuberculosis in urine by Xpert MTB/RIF Ultra: A useful adjunctive diagnostic tool in HIV-associated tuberculosis.

Atherton RR, Cresswell FV, Ellis J, Skipper C, Tadeo KK, Mugumya G, Wadda V, Meya DB, Boulware DR.

Int J Infect Dis. 2018 Oct;75:92-94. doi: 10.1016/j.ijid.2018.07.007. Epub 2018 Jul 19.

26.

Can improved diagnostics reduce mortality from Tuberculous meningitis? Findings from a 6.5-year cohort in Uganda.

Cresswell FV, Bangdiwala AS, Bahr NC, Trautner E, Nuwagira E, Ellis J, Rajasingham R, Rhein J, Williams DA, Muzoora C, Elliott AM, Meya DB, Boulware DR.

Wellcome Open Res. 2018 May 29;3:64. doi: 10.12688/wellcomeopenres.14610.2. eCollection 2018.

27.

Cerebral Oximetry for Detecting High-mortality Risk Patients with Cryptococcal Meningitis.

Diehl JW, Hullsiek KH, Okirwoth M, Stephens N, Abassi M, Rhein J, Meya DB, Boulware DR, Musubire AK; ASTRO-CM Trial Team .

Open Forum Infect Dis. 2018 May 8;5(6):ofy105. doi: 10.1093/ofid/ofy105. eCollection 2018 Jun 1.

28.

Delta-like 1 protein, vitamin D binding protein and fetuin for detection of Mycobacterium tuberculosis meningitis.

Bahr NC, Halupnick R, Linder G, Kiggundu R, Nabeta HW, Williams DA, Musubire AK, Morawski BM, Sreevatsan S, Meya DB, Rhein J, Boulware DR.

Biomark Med. 2018 Jul;12(7):707-716. doi: 10.2217/bmm-2017-0373. Epub 2018 Jun 1.

29.

A Prospective Evaluation of a Multisite Cryptococcal Screening and Treatment Program in HIV Clinics in Uganda.

Nalintya E, Meya DB, Lofgren S, Huppler Hullsiek K, Boulware DR, Rajasingham R.

J Acquir Immune Defic Syndr. 2018 Jun 1;78(2):231-238. doi: 10.1097/QAI.0000000000001669.

30.

Evaluation of trypan blue stain in the TC20 automated cell counter as a point-of-care for the enumeration of viable cryptococcal cells in cerebrospinal fluid.

Kwizera R, Akampurira A, Kandole TK, Nabaggala MS, Williams DA, Kambugu A, Meya DB, Rhein J, Boulware DR; ASTRO Team.

Med Mycol. 2018 Jul 1;56(5):559-564. doi: 10.1093/mmy/myx076.

31.

Absence of cerebrospinal fluid pleocytosis in tuberculous meningitis is a common occurrence in HIV co-infection and a predictor of poor outcomes.

Cresswell FV, Bangdiwala AS, Meya DB, Bahr NC, Vidal JE, Török ME, Thao LTP, Thwaites GE, Boulware DR.

Int J Infect Dis. 2018 Mar;68:77-78. doi: 10.1016/j.ijid.2018.01.014. Epub 2018 Jan 31. No abstract available.

32.

A Systematic Review of Non-Traumatic Spinal Cord Injuries in Sub-Saharan Africa and a Proposed Diagnostic Algorithm for Resource-Limited Settings.

Musubire AK, Meya DB, Bohjanen PR, Katabira ET, Barasukana P, Boulware DR, Meyer AC.

Front Neurol. 2017 Dec 8;8:618. doi: 10.3389/fneur.2017.00618. eCollection 2017. Review.

33.

Cryptococcal Disease in the Era of "Test and Treat": Is There Cause for Concern?

Abassi M, Rhein J, Meya DB, Boulware DR.

Open Forum Infect Dis. 2017 Dec 26;5(1):ofx274. doi: 10.1093/ofid/ofx274. eCollection 2018 Jan.

34.

Monocyte Phenotype and IFN-γ-Inducible Cytokine Responses Are Associated with Cryptococcal Immune Reconstitution Inflammatory Syndrome.

Meya DB, Okurut S, Zziwa G, Cose S, Bohjanen PR, Mayanja-Kizza H, Joloba M, Boulware DR, Yukari Manabe C, Wahl S, Janoff EN.

J Fungi (Basel). 2017 Jun 2;3(2). pii: E28. doi: 10.3390/jof3020028.

35.

Evaluation of a point-of-care immunoassay test kit 'StrongStep' for cryptococcal antigen detection.

Mpoza E, Mukaremera L, Kundura DA, Akampurira A, Luggya T, Tadeo KK, Pastick KA, Bridge SC, Tugume L, Kiggundu R, Musubire AK, Williams DA, Muzoora C, Nalintya E, Rajasingham R, Rhein J, Boulware DR, Meya DB, Abassi M.

PLoS One. 2018 Jan 5;13(1):e0190652. doi: 10.1371/journal.pone.0190652. eCollection 2018.

36.

Antimicrobial Drug Resistance in Blood Culture Isolates at a Tertiary Hospital, Uganda.

Kajumbula H, Fujita AW, Mbabazi O, Najjuka C, Izale C, Akampurira A, Aisu S, Lamorde M, Walwema R, Bahr NC, Meya DB, Boulware DR, Manabe YC.

Emerg Infect Dis. 2018 Jan;24(1):174-175. doi: 10.3201/eid2401.171112.

37.

Socioeconomic position and ten-year survival and virologic outcomes in a Ugandan HIV cohort receiving antiretroviral therapy.

Flynn AG, Anguzu G, Mubiru F, Kiragga AN, Kamya M, Meya DB, Boulware DR, Kambugu A, Castelnuovo BC.

PLoS One. 2017 Dec 15;12(12):e0189055. doi: 10.1371/journal.pone.0189055. eCollection 2017.

38.

Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in HIV-infected adults: a prospective cohort study.

Bahr NC, Nuwagira E, Evans EE, Cresswell FV, Bystrom PV, Byamukama A, Bridge SC, Bangdiwala AS, Meya DB, Denkinger CM, Muzoora C, Boulware DR; ASTRO-CM Trial Team.

Lancet Infect Dis. 2018 Jan;18(1):68-75. doi: 10.1016/S1473-3099(17)30474-7. Epub 2017 Sep 14.

39.

Evaluation of trypan blue stain in a haemocytometer for rapid detection of cerebrospinal fluid sterility in HIV patients with cryptococcal meningitis.

Kwizera R, Akampurira A, Kandole TK, Nielsen K, Kambugu A, Meya DB, Boulware DR, Rhein J; ASTRO-CM Study Team.

BMC Microbiol. 2017 Aug 22;17(1):182. doi: 10.1186/s12866-017-1093-4.

40.

Are fluconazole or sertraline dose adjustments necessary with concomitant rifampin?

Rajasingham R, Meya DB, Boulware DR.

HIV Med. 2018 Jul;19(6):e64-e65. doi: 10.1111/hiv.12543. Epub 2017 Aug 1. No abstract available.

41.

Acute Kidney Injury and Urinary Biomarkers in Human Immunodeficiency Virus-Associated Cryptococcal Meningitis.

Schutz C, Boulware DR, Huppler-Hullsiek K, von Hohenberg M, Rhein J, Taseera K, Thienemann F, Muzoora C, Meya DB, Meintjes G.

Open Forum Infect Dis. 2017 Jun 20;4(3):ofx127. doi: 10.1093/ofid/ofx127. eCollection 2017 Summer.

42.

Acridine orange fluorescent microscopy is more sensitive than India ink light microscopy in the rapid detection of cryptococcosis among CrAg positive HIV patients.

Kwizera R, Akampurira A, Williams D, Boulware DR, Meya DB; ASTRO-CM Study Team.

PLoS One. 2017 Jul 27;12(7):e0182108. doi: 10.1371/journal.pone.0182108. eCollection 2017.

43.

Neurocognitive function in HIV-infected persons with asymptomatic cryptococcal antigenemia: a comparison of three prospective cohorts.

Montgomery MP, Nakasujja N, Morawski BM, Rajasingham R, Rhein J, Nalintya E, Williams DA, Huppler Hullsiek K, Kiragga A, Rolfes MA, Donahue Carlson R, Bahr NC, Birkenkamp KE, Manabe YC, Bohjanen PR, Kaplan JE, Kambugu A, Meya DB, Boulware DR; COAT and ORCAS Trial Teams.

BMC Neurol. 2017 Jun 12;17(1):110. doi: 10.1186/s12883-017-0878-2.

44.

Evolving Failures in the Delivery of Human Immunodeficiency Virus Care: Lessons From a Ugandan Meningitis Cohort 2006-2016.

Flynn AG, Meya DB, Hullsiek KH, Rhein J, Williams DA, Musubire A, Morawski BM, Taseera K, Sadiq A, Ndyatunga L, Roediger M, Rajasingham R, Bohjanen PR, Muzoora C, Boulware DR.

Open Forum Infect Dis. 2017 Apr 19;4(2):ofx077. doi: 10.1093/ofid/ofx077. eCollection 2017 Spring.

45.

Differences in Immunologic Factors Among Patients Presenting with Altered Mental Status During Cryptococcal Meningitis.

Lofgren S, Hullsiek KH, Morawski BM, Nabeta HW, Kiggundu R, Taseera K, Musubire A, Schutz C, Abassi M, Bahr NC, Tugume L, Muzoora C, Williams DA, Rolfes MA, Velamakanni SS, Rajasingham R, Meintjes G, Rhein J, Meya DB, Boulware DR; COAT and ASTRO-CM Trial Teams.

J Infect Dis. 2017 Mar 1;215(5):693-697. doi: 10.1093/infdis/jix033.

46.

Cerebrospinal fluid biomarkers and HIV-associated neurocognitive disorders in HIV-infected individuals in Rakai, Uganda.

Abassi M, Morawski BM, Nakigozi G, Nakasujja N, Kong X, Meya DB, Robertson K, Gray R, Wawer MJ, Sacktor N, Boulware DR.

J Neurovirol. 2017 Jun;23(3):369-375. doi: 10.1007/s13365-016-0505-9. Epub 2016 Dec 19.

47.

Sertraline for HIV-associated cryptococcal meningitis - Authors' reply.

Rhein J, Nielsen K, Boulware DR, Meya DB.

Lancet Infect Dis. 2016 Oct;16(10):1111-1112. doi: 10.1016/S1473-3099(16)30340-1. Epub 2016 Sep 19. No abstract available.

48.

Activity of VT-1129 against Cryptococcus neoformans clinical isolates with high fluconazole MICs.

Nielsen K, Vedula P, Smith KD, Meya DB, Garvey EP, Hoekstra WJ, Schotzinger RJ, Boulware DR.

Med Mycol. 2017 Jun 1;55(4):453-456. doi: 10.1093/mmy/myw089.

PMID:
27664991
49.

Prognostic implications of baseline anaemia and changes in haemoglobin concentrations with amphotericin B therapy for cryptococcal meningitis.

Tugume L, Morawski BM, Abassi M, Bahr NC, Kiggundu R, Nabeta HW, Hullsiek KH, Taseera K, Musubire AK, Schutz C, Muzoora C, Williams DA, Rolfes MA, Meintjes G, Rhein J, Meya DB, Boulware DR.

HIV Med. 2017 Jan;18(1):13-20. doi: 10.1111/hiv.12387. Epub 2016 Apr 28.

50.

Implementation and Operational Research: Impact of Nurse-Targeted Care on HIV Outcomes Among Immunocompromised Persons: A Before-After Study in Uganda.

Kiragga AN, Nalintya E, Morawski BM, Kigozi J, Park BJ, Kaplan JE, Boulware DR, Meya DB, Manabe YC.

J Acquir Immune Defic Syndr. 2016 Jun 1;72(2):e32-6. doi: 10.1097/QAI.0000000000001002.

Supplemental Content

Support Center